Abbott Laboratories (ABT)
NYSE: ABT · Real-Time Price · USD
107.96
+2.25 (2.13%)
Aug 6, 2026, 4:00 PM EDT - Market closed
Abbott Laboratories Stock Forecast
Stock Price Forecast
According to 27 analysts polled by S&P Global, Abbott Laboratories stock has a consensus rating of "Buy" and an average price target of $118.42. The average 1-year stock price forecast is 9.69% higher than the current stock price, while the lowest is $103 (-4.59%) and the highest is $135 (+25.05%).
Price Target: $118.42 (+9.69%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Abbott Laboratories stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 16 | 16 | 16 | 16 | 17 | 16 |
| Buy | 6 | 6 | 5 | 4 | 4 | 4 |
| Hold | 7 | 7 | 7 | 7 | 7 | 7 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 29 | 29 | 28 | 27 | 28 | 27 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Citi | Citi | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Aug 5, 2026 |
| TD Cowen | TD Cowen | Buy Maintains $115 | Buy | Maintains | $115 | +6.52% | Jul 29, 2026 |
| UBS | UBS | Buy Reiterates $135 → $125 | Buy | Reiterates | $135 → $125 | +15.78% | Jul 28, 2026 |
Unknown Analyst Jefferies No rating | Jefferies | Buy Reiterates $135 | Buy | Reiterates | $135 | +25.05% | Jul 17, 2026 |
| Piper Sandler | Piper Sandler | Buy Reiterates $115 → $118 | Buy | Reiterates | $115 → $118 | +9.30% | Jul 17, 2026 |
Financial Forecast
Revenue This Year
50.30B
from 44.33B
Increased by 13.48%
Revenue Next Year
54.65B
from 50.30B
Increased by 8.64%
EPS This Year
5.52
from 5.15
Increased by 7.13%
EPS Next Year
6.06
from 5.52
Increased by 9.89%
EPS and Forward PE are based on non-GAAP adjusted numbers.